Find clinical trials for Triple Negative Breast Cancer in Boston, MA

This research study involves Niraparib as a possible treatment for triple negative breast cancer....

This research study is studying immunotherapy as a possible treatment for metastatic Triple Negative Breast Cancer...

This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative b ...

of durvalumab in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple...

inhibitor as a possible adjuvant treatment for Stage II or III Triple Negative Breast Cancer. This research study...

The purpose of this study is to determine if a combination of two drugs sacituzumab govitecan and atezolizumab works as a treatment for residual cancer...

This research is being done to evaluate the safety and effectiveness of Onvansertib in combination with Paclitaxel in triple-negative...

This research study is studying to evaluate sacituzumab govitecan for individuals with localized triple negative breast ca...

selective inhibition of phosphoinositide-3-kinase (PI3K)-gamma, in combinations with Tecentriq and Abraxane (nab-paclitaxel) in front-line triple...

doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...